UnitedHealth director granted 14 dividend shares
UNITEDHEALTH GROUP INC director Charles D. Baker reported a small share award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UNITEDHEALTH GROUP INC director Charles D. Baker reported a small share award. On March 17, 2026, he acquired 14 shares of Common Stock at a price of $0.00 per share as a grant/award acquisition.
According to the footnote, these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. After this transaction, Baker directly holds 1,820 shares of UnitedHealth Group common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 14 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Charles D. Baker report for UNITEDHEALTH GROUP (UNH)?
Was the UNH Form 4 transaction a market purchase or sale?
What does the dividend equivalent footnote mean in the UNH Form 4?
Does the Charles D. Baker Form 4 indicate active trading in UNH stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.